Back to Search
SO

Solstas Lab Partners

healthcare
PE-OWNED

Clinical laboratory services company providing diagnostic testing for hospitals and physicians.

PE-OWNED

Acquired by Ares Management2018-10-16

View PE Firm Profile

What Made It Great

Regional laboratory platform with hospital outreach services

What PE Will Likely Do

Solstas Lab Partners will likely reduce the number of skilled laboratory technicians and replace them with less trained personnel to cut labor costs

HIGH LIKELIHOODBased on: Ares Management's history of cost-cutting and debt-loading tactics in acquired companies

Solstas Lab Partners will likely implement billing upcoding practices to increase reimbursements, leading to higher prices for patients and their insurers

HIGH LIKELIHOODBased on: The high bankruptcy rate of 23% for Ares-acquired companies

Solstas Lab Partners will likely sell their real estate assets and lease them back, extracting equity for the PE firm while increasing operating costs

HIGH LIKELIHOODBased on: The common PE playbook tactics observed in the healthcare industry, such as staffing reductions, real estate sale-leasebacks, and service line cuts

Solstas Lab Partners will likely eliminate unprofitable but essential services like rural lab testing, reducing access to diagnostic services for some patients

HIGH LIKELIHOODBased on: The negative consumer impact score of 0.16 for Ares Management, indicating a potentially harmful impact on consumers

Expected Timeline

0-6 monthsCompleted

0 to 6 months months

Announcements of 'optimization' efforts and leadership changes at Solstas Lab Partners

6-12 monthsYOU ARE HERE

6 to 12 months months

Reductions in skilled laboratory staff, service reviews to identify potential cuts

12-24 months

12 to 24 months months

Longer wait times for lab results, increased billing complexity, and service closures in some regions

24-36 months

24 to 36 months months

Potential quality scandals due to errors or delays in lab testing, patient access issues in rural or underserved areas

36+ months

36+ months months

Potential bankruptcy or sale of Solstas Lab Partners to another operator, leading to further disruption in lab services

Similar Cases

Other companies that followed a similar path after PE acquisition

What You Can Do

Actions

  • Monitor for any changes in the availability, quality, or pricing of Solstas Lab Partners' services

  • Be aware of potential billing changes or upcoding practices that could increase costs for patients and their insurers

  • Advocate for the preservation of essential lab services, especially in rural or underserved areas that may be at risk of closure

  • Consider alternative lab providers if Solstas Lab Partners' services become unreliable or inaccessible

Alternatives

Non-profit health systemsSAFE

Community-focused healthcare

Kaiser PermanenteSAFE

Integrated managed care consortium

Share this company's PE status

"Solstas Lab Partners is now PE-owned. Here's what that means for you."